Ben Beresford-Jones

Benjamin Beresford-Jones is an MB/PhD student at the University of Cambridge (m. 2014). He is presently in the final year of his PhD at the Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Department of Medicine and is affiliated with the Wellcome Sanger Institute. Benjamin's work explores the interactions of the gut microbiota with the mucosal immune system, and the role of a host species-specific microbiome on defining outcomes of health and disease.

Benjamin has been Editor-in-Chief of the Cambridge Medicine Journal since 2017.